Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Organisation › Details

Urania Therapeutics S.A.S.

Urania Therapeutics is a privately held French biopharmaceutical company specializing in the identification and development of ‘readthrough’ compounds following a structure-based-drug design approach (SBDD). These compounds induce the overcoming of premature stop codons during protein synthesis to allow the production of missing full-length protein. In restoring production of functional protein by targeting the decoding centre of the human ribosome, the aim is to provide new therapeutic options for a vast array of monogenic diseases, such as Duchenne Muscular Dystrophy (DMD) and Cystic Fibrosis (CF), as well as certain cancer subtypes caused by nonsense mutations, a new illustration of precision medicine. Urania Therapeutics’ approach relies on the work and expertise of its scientific founders, world-leading ribosome structure experts Marat Yusupov and Gulnara Yusupova, CNRS research directors at IGBMC (Institute of Genetics and Molecular and Cellular Biology). Headquartered in Strasbourg (France), the company was created in 2015. *

 

Period Start 2015-10-06 established
  Predecessor IGBMC (Institute of Genetics and Molecular and Cellular Biology – Unistra/INSERM/CNRS, Strasbourg)
Product Industry BIOTECH
Person Person Renaud, Jean-Paul (Urania Therapeutics 201911 CSO + Founder)
     
Region Region Strasbourg
  Country France
  Street 15 Rue Neuve
  City 67540 Ostwald
    Address record changed: 2019-11-07
     
Basic data Employees n. a.
     
    * Document for �About Section�: Urania Therapeutics S.A.S.. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg.
     
   
Record changed: 2020-01-22

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Urania Therapeutics S.A.S.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px




» top